Development and validation of an early mortality risk model for pediatric hemophagocytic lymphohistiocytosis: a comparison with HScore, PELOD-2, P-MODS, and pSOFA
Annals of Hematology · 2024
DOI: 10.1007/s00277-024-05780-2 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Annals of Hematology, 2024. Verfasst von Zhexuan Tang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Pediatrics, University of South China, Changsha, China. Hauptthemen laut MEDLINE: Lymphohistiocytosis, Hemophagocytic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Department of Science and Technology of Hunan Province, Hunan Provincial Key Laboratory of emergency medicine for children, National Natural Science Foundation of China.
Abstract (Originalsprache)
There has been no severity evaluation model for pediatric patients with hemophagocytic lymphohistiocytosis (HLH) that uses readily available parameters. This study aimed to develop a novel model for predicting the early mortality risk in pediatric patients with HLH using easily obtained parameters whatever etiologic subtype. Patients from one center were divided into training and validation sets for model derivation. The developed model was validated using an independent validation cohort from the second center. The prediction model with nomogram was developed based on logistic regression. The model performance underwent internal and external evaluation and validation using the area under the receiver operating characteristic curve (AUC), calibration curve with 1000 bootstrap resampling, and decision curve analysis (DCA). Model performance was compared with the most prevalent severity evaluation scores, including the PELOD-2, P-MODS, and pSOFA scores. The prediction model included nine variables: glutamic-pyruvic transaminase, albumin, globulin, myohemoglobin, creatine kinase, serum potassium, procalcitonin, serum ferritin, and interval between onset and diagnosis. The AUC of the model for predicting the 28-day mortality was 0.933 and 0.932 in the training and validation sets, respectively. The AUC values of the HScore, PELOD-2, P-MODS and pSOFA were 0.815, 0.745, 0.659 and 0.788, respectively. The DCA of the 28-day mortality prediction exhibited a greater net benefit than the HScore, PELOD-2, P-MODS and pSOFA. Subgroup analyses demonstrated good model performance across HLH subtypes. The novel mortality prediction model in this study can contribute to the rapid assessment of early mortality risk after diagnosis with readily available parameters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Academy of Pediatrics, University of South China, Changsha, China.
- Hunan Provincial Key Laboratory of Emergency Medicine for Children, Hunan Children's Hospital, Changsha, China.
- Pediatric Intensive Care Unit (PICU), Hunan Children's Hospital, Changsha, China.
- Pediatric Research Institute of Hunan Province and Pediatric Intensive Care Unit (PICU), Hunan Children's Hospital, Changsha, China.
- Pediatric Intensive Care Unit (PICU), The First People's Hospital of Chenzhou, Chenzhou, China.
- Hunan Provincial Key Laboratory of Emergency Medicine for Children, Hunan Children's Hospital, Changsha, China. 13787252674@163.com.
Förderung
- Department of Science and Technology of Hunan Province
- Hunan Provincial Key Laboratory of emergency medicine for children
- National Natural Science Foundation of China
- Health Commission of Hunan Province
Zitieren
APA
Tang, Z., Zhu, D., Li, X., Yan, H., Luo, T., Xie, L., Yang, Y., Tang, M., Jiang, X., Huang, J., Zhang, X., Zhou, L., Lei, Y., Xiao, Z., & Lu, X. (2024). Development and validation of an early mortality risk model for pediatric hemophagocytic lymphohistiocytosis: a comparison with HScore, PELOD-2, P-MODS, and pSOFA. Annals of Hematology. https://doi.org/10.1007/s00277-024-05780-2
Vancouver
Tang Z, Zhu D, Li X, Yan H, Luo T, Xie L, et al. Development and validation of an early mortality risk model for pediatric hemophagocytic lymphohistiocytosis: a comparison with HScore, PELOD-2, P-MODS, and pSOFA. Annals of Hematology. 2024. doi:10.1007/s00277-024-05780-2
BibTeX
@article{Tang2024,
author = {Tang, Zhexuan and Zhu, Desheng and Li, Xun and Yan, Haipeng and Luo, Ting and Xie, Longlong and Yang, Yufan and Tang, Minghui and Jiang, Xuedan and Huang, Jiaotian and Zhang, Xinping and Zhou, Lifang and Lei, Yefei and Xiao, Zhenghui and Lu, Xiulan},
title = {Development and validation of an early mortality risk model for pediatric hemophagocytic lymphohistiocytosis: a comparison with HScore, PELOD-2, P-MODS, and pSOFA},
journal = {Annals of Hematology},
year = {2024},
doi = {10.1007/s00277-024-05780-2}
}
EUVIMED